| |
| |
|
| Insider
Information: |
Pickering Grant |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
524,530 |
|
|
Indirect Shares
|
146,054 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
670,584 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Sr VP, Operations |
2005-03-18 |
45,900 |
|
0 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
|
2024-05-01 |
477,847 |
2024-05-01 |
146,054 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director |
2022-03-21 |
783 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
officerTitle |
• – – |
2003-07-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,585 |
|
- |
|
| PCVX |
Vaxcyte, Inc. |
President & CEOOfficer |
• • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
571,629 |
|
- |
|
| PCVX |
Vaxcyte, Inc. |
President & CEOOfficer |
• • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
355,660 |
|
- |
|
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2022-03-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
783 |
|
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-22 |
4 |
AS |
$22.00 |
$1,628 |
D/D |
(74) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-22 |
4 |
OE |
$1.79 |
$132 |
D/D |
74 |
580,328 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2022-06-24 |
4 |
AS |
$21.01 |
$15,696 |
D/D |
(747) |
694,456 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-21 |
4 |
AS |
$22.05 |
$23,439 |
D/D |
(1,063) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-21 |
4 |
OE |
$1.79 |
$1,903 |
D/D |
1,063 |
581,317 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2022-06-22 |
4 |
AS |
$21.01 |
$26,492 |
D/D |
(1,261) |
698,744 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-19 |
4 |
OE |
$1.79 |
$2,382 |
D/D |
1,331 |
581,585 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-19 |
4 |
AS |
$22.40 |
$29,810 |
D/D |
(1,331) |
580,254 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Sr VP, Operations |
• – – |
2005-03-18 |
4 |
OE |
$1.82 |
$3,640 |
D/D |
2,000 |
45,900 |
|
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
AS |
$62.91 |
$167,144 |
I/I |
(2,616) |
151,286 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-01 |
4 |
AS |
$71.93 |
$193,353 |
I/I |
(2,616) |
149,978 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-01 |
4 |
AS |
$72.97 |
$192,799 |
I/I |
(2,616) |
148,670 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-01 |
4 |
AS |
$66.45 |
$174,502 |
I/I |
(2,616) |
147,362 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-05-01 |
4 |
AS |
$61.25 |
$161,419 |
I/I |
(2,616) |
146,054 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-09-25 |
4 |
AS |
$52.42 |
$137,264 |
I/I |
(2,618) |
156,521 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-10-02 |
4 |
AS |
$49.67 |
$131,996 |
I/I |
(2,618) |
155,212 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-12-01 |
4 |
AS |
$51.43 |
$136,442 |
I/I |
(2,618) |
152,594 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-28 |
4 |
AS |
$22.16 |
$58,857 |
D/D |
(2,656) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-28 |
4 |
OE |
$1.79 |
$4,754 |
D/D |
2,656 |
582,910 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Sr VP, Operations |
• – – |
2005-03-18 |
4 |
B |
$5.63 |
$16,890 |
D/D |
3,000 |
43,900 |
2.74 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-03-02 |
4 |
D |
$41.49 |
$128,578 |
D/D |
(3,099) |
425,252 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
